Affibody

Sinking deal terminated sunk deal ends
Biotech

Affibody regains drug, says ex-ally unable to capitalize on data

Acelyrin has punted the autoimmune drug prospect izokibep back to Affibody, completing a retreat from its former lead candidate that began in August.
Nick Paul Taylor Feb 3, 2025 5:18am
A doctor with a graphic representation of the lungs

Chiesi, Affibody sign $637M respiratory disease collab

Mar 7, 2023 11:15am